HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1986523Generated: November 2, 2026
Water → 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(piperazin-1-yl)-xanthine
https://huagongshe.com/reaction/1986523
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Sodium Chloride | HCID 5234 | — |
| Reactant | 8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione | HCID 24750049 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(piperazin-1-yl)-xanthine | HCID 11374531 | — |
Reaction Steps
A mixture of 300 mg of 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine and 290 mg of piperazine in 5 ml of N,N-dimethylformamide is heated at 200° C. for 5 min in a microwave oven. After cooling to room temperature, the reaction mixture is treated with water and saturated sodium chloride solution and extracted with ethyl acetate. The organic phase is washed with saturated sodium chloride solution, dried over magnesium sulphate and concentrated. The solid flask residue is triturated with diethyl ether, filtered off with suction and dried at 45° C. in a circulating air drying oven.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07550455B2 |
|---|
| Source dataset | uspto-grants-2009_06 |
|---|
| ORD ID | ord-4b9f201103714d1f8ff6fb7085877fc7 |
|---|
| Source note | uspto-grants-2009_06 |
|---|